Navigation Links
Valeant Announces Pricing of Senior Notes
Date:3/3/2011

MISSISSAUGA, Ontario, March 3, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") announced today that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect subsidiary, has priced its previously announced offering of senior unsecured notes, which consists of $950 million aggregate principal amount of 6.500% Senior Notes due 2016 and $550 million aggregate principal amount of 7.250% Senior Notes due 2022 (collectively, the "Notes"). The offering is expected to close on or about March 8, 2011.

The Notes will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to qualified institutional buyers under Rule 144A of the Securities Act and outside the United States under Regulation S of the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

The Notes will be guaranteed by the Company and each of the Company's subsidiaries (other than Valeant) that is a guarantor under Valeant's other senior notes.

Valeant intends to use the net proceeds from the offering of the Notes to prepay the amounts outstanding under its term loan A facility (and cancel the undrawn senior secured revolving credit facility); to fund the $275 million repurchase of shares of the Company's common shares from ValueAct Capital Master Fund, L.P. pursuant to the terms of a recently announ
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... GLEN BURNIE, Md. , April 1, 2015 ... in patient recruitment solutions for the clinical research ... to help with a dermatology study that was ... its expert recruitment strategies and customized site support ... was screening and enrolling, and also increased the ...
(Date:4/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kz78wm/medical_device ) ... Device Studies: Clinical Evidence" conference to their ... specifically for those who are involved in gathering ... diagnostic products. Clinical data is required for all ... appropriate clinical evidence has grown substantially in the ...
(Date:4/1/2015)... Md. , April 1, 2015  RegeneRx ... today announced that a new medical paper has ... beta 4 (TB4) in patients with severe dry ... the study and the physicians stated that statistically ... severe dry eye were seen at various time ...
Breaking Medicine Technology:CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... May 27 The Department of Veterans Affairs (VA) ... arm that easily allows those with severe limb loss ... arm is a high-tech example of how VA researchers ... of artificial limbs to meet Veterans, lifestyle and medical ...
... data with PROSTVAC(TM) - a promising, late-stage vaccine,candidate for the ... Q&A session at the ASCO Annual Meeting. , ... EDT to 10 AM EDT. , ... At the Q&A session, Bavarian Nordic,s ...
Cached Medicine Technology:VA Studies Advanced Prosthetic Arm 2
(Date:4/1/2015)... 2015 When annoying or concerning skin ... or weeks for an appointment with a dermatologist is ... day appointments haven’t been possible within dermatology. However, in ... have noticed demand for this level of service and ... important relief or answers to dermatological issues are to ...
(Date:4/1/2015)... 2015 SkillSurvey, the leading provider of ... lifecycle, and the premiere provider of on-line automated reference ... a webinar on “Using Big Data to Recruit Millennials.” ... resources officer of MorseLife, a nationally recognized provider of ... their families in Palm Beach County. , “As the ...
(Date:4/1/2015)... 2015 Franklin University, one of the ... the establishment of the Greta J. Russell Medical Mutual ... through the generous gift of $100,000 from Medical Mutual ... of Medical Mutual to University representatives, Dr. David ... Advancement & Strategic Relations. , “We are grateful ...
(Date:4/1/2015)... NC (PRWEB) April 01, 2015 Doctors ... immunotherapy drug tremelimumab is more effective against mesothelioma at ... the research on its website. Click here to ... 29 patients at the University Hospital of Siena with ... grow after standard chemotherapy. When these patients received monthly ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Eighty seven ... athletics grants from California Casualty . Many of ... reduced-cost lunches and subsequently have fewer and fewer dollars ... after California Casualty Chairman Emeritus Thomas R. Brown, who ... to the classroom. Since its inception in 2011, ...
Breaking Medicine News(10 mins):Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3Health News:New Research Finds Immunotherapy Drug May Fight Mesothelioma Better at Higher Doses, According to Surviving Mesothelioma 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5
... increasing number of countries can now take advantage of ... of osteoporosis. , FRAX, which is freely available ... was developed by Professor John A. Kanis and colleagues ... at the University of Sheffield Medical School in the ...
... Calif., Jan. 30 Diagnosoft, Inc., an innovator ... assists in diagnosis, staging and therapeutic monitoring of ... Diagnosoft(R) SENC. Strain-encoding, or SENC, is a ... measure regional contraction, or relaxation, of the heart,s ...
... LAKES, N.J., Jan. 30 Medco Health Solutions, Inc. (NYSE: ... full-year 2008 financial results in a press release before the ... release, management will hold a conference call to review the ... To access the live conference call via telephone: ...
... -- Tianyin,Pharmaceutical, Co., Inc. (NYSE Alternext: TPI), a ... based in Chengdu, China,today announced that the Company ... previously announced stock repurchase program. These shares will ... of outstanding shares of its,common stock. , ...
... of Trimlife ( www.trimlife.com ), a nutritional supplement company ... Company, LLC of Fort Lee, NJ, commonly known as ... product Lipitone ( www.lipitone.com ) and other supplements.TNC plans ... additional wellness products and services on an aggressive timetable, ...
... CEO of America,s Health Insurance Plans (AHIP), today issued ... to reauthorize and expand the State Children,s Health Insurance ... is an essential component of comprehensive health care reform. ... by voting to help ensure that no child falls ...
Cached Medicine News:Health News:FRAX tool now available for use in 12 countries 2Health News:Diagnosoft(R) Introduces Its Third MRI Analysis Innovation 2Health News:Medco Announces Date for Fourth-Quarter and Full-Year 2008 Financial Results 2Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 3Health News:The Neutraceutical Company, LLC Grows Wellness Enhancement Business with Acquisition of North Dakota Based Trimlife.com 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: